ETFs
T
TENX
Tenax Therapeutics Inc
1.590
+0.070+4.61%Opening12:58 10/20 EDT
OPEN/PREV CLOSE1.500/1.520
TODAY RANGE1.500-1.610
VOL800.95K
MARKET CAP59.50M
52 WEEK RANGE1.310-19.40
AVG VOL (3M)5.65M
% TURNOVER2.14%
TURNOVER--
P/E (TTM)-1.0781
% RANGE7.24%
EPS(TTM)-1.4748
P/E(FORWARD)0.0000
P/B0.4472
BVPS3.555
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP56.61M
SHARES OUTSTANDING37.42M
NEXT EARNINGS11/10-11/16
FREE FLOAT35.60M
LOT SIZE1
EX-DATE01/03/2024
News
Press Releases
Financial Reports
Profile
TipRanks·10/12 09:26
Tenax Therapeutics (TENX) Receives a Rating Update from a Top Analyst
TipRanks·10/08 20:50
Tenax pauses Phase 3 levosimendan trial to refine criteria
NASDAQ·09/21 17:36
Monday 9/21 Insider Buying Report: TH, TENX
TipRanks·09/15 11:45
Piper Sandler Remains a Buy on Tenax Therapeutics (TENX)
TipRanks·09/09 12:41
Tenax Therapeutics Updates Phase 3 LEVEL Trial Strategy
TipRanks·09/03 02:07
Major Investment Firm Quietly Makes Bold Move Into Tenax Therapeutics
Benzinga·09/01 07:27
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month
Benzinga·08/31 17:06
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·08/31 16:01
Midday Fly By: Aon buying USI, Lilly to acquire Merida
TipRanks·08/31 13:50
Deere upgraded, Lumentum initiated: Wall Street’s top analyst calls
Benzinga·08/31 13:18
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Dow Jones·08/31 13:06
Tenax Therapeutics Cut to Neutral From Buy by Guggenheim
Benzinga·08/31 12:55
Guggenheim Downgrades Tenax Therapeutics to Neutral
Same Industry
Name/Symbol
Change%
Price